loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Levoketoconazole

    Client Email Product
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Levoketoconazole KP

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Levoketoconazole

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xeris' Levoketoconazole Effects In Cushing's Syndrome At ENDO
    Xeris' Levoketoconazole Effects In Cushing's Syndrome At ENDO

    03 Jun 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240603311134/en

    BUSINESSWIRE
    03 Jun 2024
    Share Share
    Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev
    Xeris Biopharma Announces FDA Grants Orphan-drug Exclusivity for Recorlev

    31 Jan 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230130005152/en/Xeris-Biopharma-Announces-FDA-Grants-Orphan-drug-Exclusivity-for-Recorlev%C2%AE

    BUSINESSWIRE
    31 Jan 2023
    Share Share
    Xeris Biopharma Announces Recorlev Is Now Commercially Available
    Xeris Biopharma Announces Recorlev Is Now Commercially Available

    31 Jan 2022

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20220131005297/en

    BUSINESSWIRE
    31 Jan 2022
    Share Share
    Xeris Biopharma Announces U.S. FDA Approval of Recorlev®
    Xeris Biopharma Announces U.S. FDA Approval of Recorlev®

    30 Dec 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211230005308/en

    BUSINESSWIRE
    30 Dec 2021
    Share Share
    Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results
    Strongbridge Biopharma plc Reports Third Quarter 2020 Financial Results

    29 Oct 2020

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2020/10/29/2117303/0/en/Strongbridge-Biopharma-plc-Reports-Third-Quarter-2020-Financial-Results-and-Provides-Corporate-Update.html

    GLOBENEWSWIRE
    29 Oct 2020
    Share Share
    Strongbridge Biopharma plc Provides Corporate Update
    Strongbridge Biopharma plc Provides Corporate Update

    08 Sep 2020

    // GLOBENEWS WIRE

    https://www.globenewswire.com/news-release/2020/09/08/2090019/0/en/Strongbridge-Biopharma-plc-Provides-Corporate-Update.html

    GLOBENEWS WIRE
    08 Sep 2020
    Share Share